Elevance Health reported $201.1B of revenue over the trailing twelve months, +6.3% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $201.1B (to Q2 2026). Net Income: $4.96B, trailing twelve months to Q2 2026. Free Cash Flow: $6.29B, trailing twelve months to Q2 2026. Op Margin: 2.7%, trailing twelve months to Q2 2026.

ELVElevance Health

HealthcareUSD

$402.55

$277.6552 weeks$430.21

ELV as reported

Elevance Health reported $201.1B of revenue over the trailing twelve months, +6.3% on the year before. 11 reported series are charted on this page, each one as filed.

$201.1B

Revenue, trailing twelve months · to Q2 2026 · +6.3% against the twelve months before

Net Income: $4.96B
Net Income · −7.4% year on year · trailing twelve months to Q2 2026
Free Cash Flow: $6.29B
Free Cash Flow · +18% year on year · trailing twelve months to Q2 2026
Op Margin: 2.7%
Op Margin · trailing twelve months to Q2 2026

Every series Ryufin has for ELV, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$201.1B	+6.3%	Q2 2026
Net Income	$4.96B	−7.4%	Q2 2026
EPS	$22.57	−4.2%	Q2 2026
Gross Margin	89%	n/a	Q2 2026
Op Margin	2.7%	n/a	Q2 2026
Net Margin	2.5%	n/a	Q2 2026
ROE	12%	n/a	Q2 2026
ROA	4.3%	n/a	Q2 2026
ROIC	13%	n/a	Q2 2026
Free Cash Flow	$6.29B	+18%	Q2 2026
P/E	17.8	n/a	today